Apex Healthcare Berhad (KLSE:AHEALTH)

Market Cap	1.54B
Revenue (ttm)	952.47M
Net Income (ttm)	72.92M
Shares Out	720.39M
EPS (ttm)	0.10
PE Ratio	21.00
Forward PE	17.73
Dividend	0.09 (4.21%)
Ex-Dividend Date	May 30, 2025

Volume	23,600
Average Volume	38,235
Open	2.130
Previous Close	2.140
Day's Range	2.130 - 2.140
52-Week Range	1.900 - 2.890
Beta	0.29
RSI	48.26
Earnings Date	Aug 20, 2025

About Apex Healthcare Berhad

Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates in three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, anti-diabetic, anti-hypertensive, neuromuscular agent, analgesic, dermatological, and ophthalmological products in the form of tablets, capsules, oral liq...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 976
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: AHEALTH

Financial Performance

In 2024, Apex Healthcare Berhad's revenue was 961.78 million, an increase of 2.74% compared to the previous year's 936.17 million. Earnings were 76.54 million, a decrease of -80.77%.